Jul 19, 2016
One of the latest stocks to list on the ASX happens to have a very small market cap, but a very advanced oncology drug with early sales potential. This $15M capped stock just raised $4M as part of its entry to the ASX, and its inherent value is in a niche cancer drug named Bisantrene that was ‘lost’ in the 1990s – buried under the weight of so-called billion-dollar blockbuster drugs that better suit Big Pharma’s margins.
Jul 5, 2016
There are just 32 companies in Canada that have a license to grow medical cannabis – and MMJ PhytoTech, Ltd (ASX:MMJ) has just officially joined their ranks – the first ASX listed company to do so. A licence to grow medicinal cannabis is not easy to get your hands on in Canada – over 1200 companies have tried, and over 1000 have failed or given up – indicating the stringent nature of the country’s health regulators.
Jun 14, 2016
With a total global market of $90 billion, successful hair loss products can generate hundreds of millions of dollars in revenue. However the current market leaders may soon be under pressure from one particular ASX listed life sciences company.
Jun 8, 2016
Prominent US financial institution JP Morgan recently released a rather bullish report on Alzheimer’s disease – a sector they think represents one of the most attractive up and coming categories in biotech.
May 31, 2016
When the US Food and Drug Administration (FDA) gives companies its seal of approval, it usually signals the start of a fully endorsed, regulatory-approved push into large commercial markets. No matter what industry a company operates in, FDA product approval is a big milestone.
May 25, 2016
Within the next quarter, $12M capped Dimerix (ASX:DXB) is due to publish early results from Phase II clinical trials of its flagship drug therapy DMX-200, a combination therapy designed to alleviate the suffering of people afflicted with Chronic Kidney Disease (CKD).
May 4, 2016
We’ve been highlighting the changing landscape in the medical cannabis industry for quite a while. Forgotten for decades, cannabis is coming back as a soft medicine as governments the world over reconsider draconian drug enforcement policy that in hindsight, was throwing the baby out with the bathwater.
Apr 20, 2016
As humans continue to live longer, certain diseases start to become more apparent, causing widespread concern for the elderly and their families. One of them is Alzheimer’s disease (AD) – a horrific disease that starts off with short-term memory loss and gradually progresses to severe memory failure including forgetting your own children and family.
Apr 1, 2016
The market for medical cannabis is gradually moving out of the wilderness and onto government radars. The once forgotten medicine is currently being re-evaluated and reclassified in the US, Australia and Europe as its positive effect on a range of ailments is finally being rediscovered and decriminalised by governments across the globe.
Mar 15, 2016
Kidneys are the unsung heroes of our bodies. You may not think about it often, but your healthy kidney keeps your blood pressure regular, filters waste and toxins (i.e. adds water and creates urine), and cleans your blood.